567 related articles for article (PubMed ID: 19549621)
1. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
[TBL] [Abstract][Full Text] [Related]
2. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
[TBL] [Abstract][Full Text] [Related]
3. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Kwon DH; Setser RM; Thamilarasan M; Popovic ZV; Smedira NG; Schoenhagen P; Garcia MJ; Lever HM; Desai MY
Heart; 2008 Oct; 94(10):1295-301. PubMed ID: 17690158
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
[TBL] [Abstract][Full Text] [Related]
5. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
[TBL] [Abstract][Full Text] [Related]
7. [Aortic regurgitation in hypertrophic cardiomyopathy as detected by color Doppler echocardiography].
Shiota T; Sakamoto T; Amano K; Hada Y; Takenaka K; Hasegawa I; Takahashi T; Suzuki J; Takahashi H; Sugimoto T
J Cardiol; 1987 Dec; 17(4):759-68. PubMed ID: 3506602
[TBL] [Abstract][Full Text] [Related]
8. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging.
White RD; Obuchowski NA; Gunawardena S; Lipchik EO; Lever HM; Van Dyke CW; Lytle BW
Am J Card Imaging; 1996 Jan; 10(1):1-13. PubMed ID: 8680128
[TBL] [Abstract][Full Text] [Related]
10. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
11. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
[TBL] [Abstract][Full Text] [Related]
12. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
[TBL] [Abstract][Full Text] [Related]
13. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study.
Austin BA; Popovic ZB; Kwon DH; Thamilarasan M; Boonyasirinant T; Flamm SD; Lever HM; Desai MY
Heart; 2010 Aug; 96(16):1303-10. PubMed ID: 20659950
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
[TBL] [Abstract][Full Text] [Related]
15. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
[TBL] [Abstract][Full Text] [Related]
17. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
Harrigan CJ; Appelbaum E; Maron BJ; Buros JL; Gibson CM; Lesser JR; Udelson JE; Manning WJ; Maron MS
Am J Cardiol; 2008 Mar; 101(5):668-73. PubMed ID: 18308018
[TBL] [Abstract][Full Text] [Related]
18. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.
Boonyasirinant T; Rajiah P; Setser RM; Lieber ML; Lever HM; Desai MY; Flamm SD
J Am Coll Cardiol; 2009 Jul; 54(3):255-62. PubMed ID: 19589439
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
[TBL] [Abstract][Full Text] [Related]
20. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation.
Dimitrow PP; Undas A; Bober M; Tracz W; Dubiel JS
Heart; 2008 Jun; 94(6):e21. PubMed ID: 17923461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
